In vitro methods for the assessment of permeability

Oral Drug Absorption: Prediction and Assessment

Volumn , Issue , 2000, Pages 51-72

  Tukker, Josef J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84962048349     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (37)

1. RT Borchardt, PL Smith, G Wilson. Models for Assessing Drug Absorption and Metabolism. New York: Plenum Press, 1996.
2. I Osiecka, PA Porter, RT Borchardt, JA Fix, CR Gardner. In vitro drug absorption models. I. Brush border membrane vesicles, isolated mucosal cells and everted intestinal rings: characterization and salicylate accumulation. Pharm Res 1985; 2: 284-293.
3. C Pidgeon, S Ong, H Liu, X Qiu, M Pidgeon, AH Dantzig, J Munroe, WJ Horn-back, JS Kasher, L Glunz, T Szczerba. IAM chromatography: an in vitro screen for predicting drug membrane permeability. J Med Chem 1995; 38: 590-594.
4. JA Fix. Intestinal rings and isolated intestinal mucosal cells. In: RT Borchardt, PL Smith, G Wilson, eds. Models for Assessing Drag Absorption and Metabolism. New York: Plenum Press, 1996; 51-66.
5. PS Leppert, J A Fix. Use of everted intestinal rings for in vitro examination of oral absorption potential. J Pharm Sci 1994; 83: 976-981.
6. AS Uch, U Hesse, JB Dressman. Use of 1 -methyl-pyrrolidone as a solubilizing agent for determining the uptake of poorly soluble drugs. Pharm Res 1999; 16: 968-971.
7. BH Stewart, AR Kugler, PR Thompson, HN Bockbrader. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drag levels in plasma. Pharm Res 1993; 10: 276-281.
8. KC Meadows, JB Dressman. Mechanism of acyclovir uptake in rat jejunum. Pharm Res 1990; 7: 299-303.
9. PA Porter, I Osiecka, RT Borchardt, JA Fix, L Frost, C Gardner. In vitro drug absorption models. II. Salicylate, cefoxitin, a-methyldopa and theophylline uptake in cells and rings: correlation with in vivo bioavailability. Pharm Res 1985; 2: 293-298.
10. JS Kim, RL Oberle, DA Krummel, JB Dressman, D Fleisher. Absorption of ACE inhibitors from small intestine and colon. J Pharm Sci 1994; 83: 1350-1356.
11. TH Wilson, G Wiseman. The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface. J Physiol 1954; 123: 116-125.
12. A Yamamoto, T Kawaratani, K Kawashima, M Hashida, H Sezaki. Intestinal transport of sulfanilic acid in rats immunized with protein-sulfanilic acid conjugate. Pharm Res 1990; 7: 767-771.
13. JT Pento, GK Mousissian. Time-dependent deterioration of active transport in duodenal segments of rat intestine. J Pharmacol Methods 1988; 20: 9-14.
14. L Barthe, JF Woodley, S Kenworthy, G Houin. An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine. Eur J Drug Metab Pharmacokinet 1998; 23: 313-323.
15. M Tomita, M Shiga, M Hayashi, S Awazu. Enhancement of colonic drug absorption by the paracellular permeation route. Pharm Res 1988; 5: 341-346.
16. R Bouer, L Barthe, C Philibert, C Tournaire, J Woodley, G Houin. The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac. Fundam Clin Pharmacol 1999; 13: 494-500.
17. HH Ussing, K Zerahn. Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. Acta Physiol Scand 1951; 23: 110-127.
18. GM Grass, SA Sweetana. In vitro measurement of gastrointestinal tissue permeability using a new diffusion cell. Pharm Res 1988; 5: 372-376.
19. PL Smith. Methods for evaluating intestinal permeability and metabolism in vitro. In: RT Borchardt, PL Smith, G Wilson, eds. Models for Assessing Drug Absorption and Metabolism. New York: Plenum Press, 1996:13-34.
20. P-Y Yeh, PL Smith, H Ellens. Effect of medium-chain glycerides on physiological properties of rabbit intestinal epithelium in vitro. Pharm Res 1994; 11: 1148- 1154.
21. BI Polentarutti, AL Peterson, AK Sjöberg, EKI Anderberg, LM Utter, A LB Ungell. Evaluation of viability of excised rat intestinal segments in the Ussing chamber: investigation of morphology, electrical parameters, and permeability constants. Pharm Res 1999; 16: 446-454.
22. A-L Ungell, S Nylander, S Bergstrand, Å Sjöberg, H Lennernäs. Membrane transport of drugs in different regions of the intestinal tract of the rat. J Pharm Sci 1998; 87: 360-366.
23. C-P Lee, RLA de Vrueh, PL Smith. Selection of development candidates based on in vitro permeability measurements. Adv Drug Deliv Rev 1997; 23: 47-62.
24. BH Stewart, OH Chan, N Jezyk, D Fleisher. Discrimination between drug candidates using models for evaluation of intestinal absorption. Adv Drug Deliv Rev 1997; 23: 27-45.
25. W Rubas, N Jezyk, GM Grass. Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharm Res 1993; 10: 113-118.
26. L Barthe, J Woodley, G Houin. Gastrointestinal absorption of drugs: methods and studies. Fundam Clin Pharmacol 1999; 13: 154-168.
27. J Fogh, JM Fogh, Orfeo T. 127 cultured human colon cell lines producing tumors in nude mice. J Natl Acad Sci USA 1977; 7: 221-226.
28. IJ Hidalgo. Cultured intestinal epithelial cell models. In: RT Borchardt, PL Smith, G Wilson, eds. Models for Assessing Drug Absorption and Metabolism. New York: Plenum Press, 1996:35-50.
29. L-S Gan, C Eads, T Niederer, A Bridgers, S Yanni, P-H Hsyu, FJ Pritchard, DR Thakker. Use of Caco-2 cells as an in vitro intestinal absorption and metabolism model. Drug Dev Ind Pharm 1994; 20: 615-631.
30. L-SL Gan, DR Thakker. Applications of the Caco-2 model in the design and the development of orally active drags: elucidation of biochemical and physical harriers posed by the intestinal epithelium. Adv Drug Deliv Rev 1997; 23: 77-98.
31. W Rubas, MEM Cromwell, Z Shahrokh, J Villagran, T-N Nguyen, M Wellton, T-H Nguyen, RJ Mrsny. Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue. J Pharm Sci 1996; 85: 165-169.
32. P Garberg, P Eriksson, N Schipper, B Sjöström. Automated absorption assessment using Caco-2 cells cultured on both sides of polycarbonate membranes. Pharm Res 1999: 16:441-445.
33. SD Raessi, JJ Hidalgo. J Segura-Aquilar, P Artursson, Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal Caco-2 (TC7) cell monolayers. Pharm Res 1999; 16: 625-632.
34. ME Dowty, CR Dietsch. Improved prediction of in vivo peroral absorption from in vitro intestinal permeability using an internal standard to control for intra- and interrat variability. Pharm Res 1997; 14: 1792-1797.
35. BH Stewart, OH Chan, RH Lu, EL Reyner, HL Schmid, HW Hamilton, BA Steinbauch, MD Taylor. Comparison of intestinal penneabililies determined in multiple in vitro and in situ models: relationship to absorption in humans. Pharm Res 1995; 12: 693-699.
36. N Jezyk, C Li, BH Stewart, X Wu, HN Brockbradcr, D Fleisher. Transport of pregabalin in rat intestine and Caco-2 monolayers. Pharm Res 1999; 16: 519-526.
37. P Artursson, A-L Ungell, J-E Löfroth. Selective paracellular permeability in two models of intestinal absorption: cultured monolayers uf human intestinal epithelial cells and rat intestinal segments. Pharm Res 1993; 10: 1123-1129.